Bacterial acetylation of 5-aminosalicylic acid in faecal suspensions cultured under aerobic and anaerobic conditions

Absorption, metabolism, and excretion of salicylazosulfapyridine in man

Schröder, H., & Campbell, D. E. S. (1972) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1972134539 · Cited by 326 · see citing works

5-Aminosalicylic Acid in a Slow-Release Preparation: Bioavailability, Plasma Level, and Excretion in Humans

Rasmussen, S. N., Bondesen, S., HVIDBERG, E. F., Hansen, S. H., Binder, V., Halskov, S., & Flachs, H. (1982) · Gastroenterology · doi:10.1016/s0016-5085(82)80075-9 · Cited by 223 · see citing works

An oral preparation to release drugs in the human colon.

Dew, M. J., Hughes, P., Lee, M., Evans, B., & Rhodes, J. (1982) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1982.tb01999.x · Cited by 186 · see citing works

Distribution and metabolism in healthy volunteers of disodium azodisalicylate, a potential therapeutic agent for ulcerative colitis.

Willoughby, C. P., Aronson, J. K., Agback, H., Bodin, N., & Truelove, S. C. (1982) · Gut · doi:10.1136/gut.23.12.1081 · Cited by 149 · see citing works

Colonic Azodisalicylate Metabolism Determined by In Vivo Dialysis in Healthy Volunteers and Patients With Ulcerative Colitis

Lauritsen, K., Hansen, J. P. H., Ryde, M., & Rask-Madsen, J. (1984) · Gastroenterology · doi:10.1016/s0016-5085(84)80164-x · Cited by 140 · see citing works

5-Aminosalicylic Acid in the Treatment of Crohn's Disease: A 16-Week Double-Blind, Placebo-Controlled, Multicentre Study with Pentasa®

Rasmussen, S. N., Lauritsen, K., Tage‐Jensen, U., Nielsen, O. H., Bytzer, P., Jacobsen, O., Ladefoged, K., VILIEN, M., Binder, V., Rask-Madsen, J., et al. (1987) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528708991929 · Cited by 131 · see citing works

Maintenance of remission in ulcerative colitis with oral preparation of 5-aminosalicylic acid.

Dew, M. J., Hughes, P., Harries, A. D., Williams, G., Evans, B. K., & Rhodes, J. (1982) · BMJ · doi:10.1136/bmj.285.6347.1012 · Cited by 125 · see citing works

The Effect of TopicalN-Acetyl-5-Aminosalicylic Acid in Ulcerative Colitis

Willoughby, C. P., Piris, J., & Truelove, S. C. (1980) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528009181520 · Cited by 79 · see citing works

Double‐blind comparison of 5‐aminosalicylic acid and acetyl‐5‐aminosalicylic acid suppositories in patients with idiopathic proctitis

van Hogezand, R. A., van Hees, P. A. M., GORP, J. P. W. M. V., van Lier, H. J. J., Bakker, J., Wesseling, P., van Haelst, U. J. G. M., & van Tongeren, J. H. M. (1988) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1988.tb00668.x · Cited by 59 · see citing works

Disposition of disodium azodisalicylate in healthy subjects

van Hogezand, R. A., van Hees, P. A. M., Zwanenburg, B., van Rossum, J. M., & van Tongeren, J. H. M. (1985) · Gastroenterology · doi:10.1016/0016-5085(85)90142-8 · Cited by 57 · see citing works

A new slow-release form of 5-aminosalicylic acid for the oral treatment of inflammatory bowel disease. Biopharmaceutic and clinical pharmacokinetic characteristics.

Klotz, U. E., Maier, K., Fischer, C., & Bauer, K. (1985) · PubMed · Cited by 48 · see citing works

Role of the intestinal flora in the acetylation of sulfasalazine metabolites

Dull, B. J., Salata, K., & Goldman, P. (1987) · Biochemical Pharmacology · doi:10.1016/0006-2952(87)90034-7 · Cited by 42 · see citing works

Capacity-limited Gut Wall Metabolism of 5-aminosalicylic acid, a Therapeutically Active Metabolite of Sulfasalazine, in Rats

Pieniaszek, H. J., & Bates, T. R. (1979) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600681036 · Cited by 41 · see citing works

Determination of sodium azodisalicylate, salazosulphapyridine and their metabolites in serum, urine and faeces by high-performance liquid chromatography

van Hogezand, R. A., van Balen, H. C. J. G., van Schaik, A., Tangerman, A., van Hees, P. A. M., Zwanenburg, B., & van Tongeren, J. H. M. (1984) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(00)83364-2 · Cited by 29 · see citing works

Absorption, enterohepatic circulation, and excretion of 5-aminosalicylic acid in rats.

Shafii, A., Chowdhury, & Das, K. M. (1982) · PubMed · Cited by 23 · see citing works

Use of Combusted Natural Gas to Cultivate the Anaerobic Bacterial Flora from the Cecum Contents of Mice

Koopman, J. P., Oeveren, J. P. V., & Janssen, F. G. J. (1973) · Applied Microbiology · doi:10.1128/am.26.4.584-588.1973 · Cited by 22 · see citing works

Oxygen radical injury in the presence of desferal, a specific iron-chelating agent

Gupta, M., & Singal, P. K. (1987) · Biochemical Pharmacology · doi:10.1016/0006-2952(87)90035-9 · Cited by 18 · see citing works

Epidemiology of NSAID‐induced gastrointestinal problems and the role of cimetidine in their prevention

GIERCKSKY, K., Husby, G., Rugstad, H. E., & Revhaug, A. (1988) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1988.tb00763.x · Cited by 18 · see citing works

Association of germfree mice with bacteria isolated from the intestinal tract of "normal" mice.

Koopman, J. P., Prins, R. A., Mullink, J. W. M. A., Welling, G. W., Kennis, H. M., & Hectors, M. P. C. (1983) · PubMed · Cited by 18 · see citing works

Partial Fundectomy Results in Hypergastrinaemia and the Development of Gastric ECL Cell Carcinoids in the Rat

Havu, N., Mattsson, H., Carlsson, K., Lundell, L., Carlsson, E. I., & Bräutigam, J. (1989) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528909091272 · Cited by 14 · see citing works

5-Aminosalicylic acid in patients with an ileo-rectal anastomosis

Bondesen, S., Tage‐Jensen, U., Jacobsen, O., Hansen, S. H., Rasmussen, S. N., & HVIDBERG, E. F. (1986) · European Journal of Clinical Pharmacology · doi:10.1007/bf00870980 · Cited by 11 · see citing works

Use of Combusted Natural Gas to Cultivate the Anaerobic Bacterial Flora from the Cecum Contents of Mice

Koopman, J. P., Oeveren, J. P. V., & Janssen, F. G. J. (1973) · Applied Microbiology · doi:10.1128/aem.26.4.584-588.1973 · Cited by 9 · see citing works

Chemical transformation of xenobiotics by the human gut microbiota

Koppel, N., Maini Rekdal, V., & Balskus, E. P. (2017) · Science · doi:10.1126/science.aag2770 · Cited by 1,080 · see citing works

Gut microbiome interactions with drug metabolism, efficacy, and toxicity

Wilson, I. D., & Nicholson, J. K. (2017) · Translational Research · doi:10.1016/j.trsl.2016.08.002 · Cited by 656 · see citing works

The gastrointestinal microbiota as a site for the biotransformation of drugs

Sousa, T., Paterson, R., Moore, V., Carlsson, A., Abrahamsson, B., & Basit, A. W. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.07.009 · Cited by 618 · see citing works

Gut reactions: Breaking down xenobiotic–microbiome interactions

Clarke, G., Sandhu, K. V., Griffin, B. T., Dinan, T. G., Cryan, J. F., & Hyland, N. P. (2019) · Pharmacological Reviews · doi:10.1124/pr.118.015768 · Cited by 319 · see citing works

Gut microbial metabolism of 5-ASA diminishes its clinical efficacy in inflammatory bowel disease

Mehta, R. S., Mayers, J. R., Zhang, Y., Bhosle, A., Glasser, N. R., Nguyen, L. H., Ma, W., Bae, S., Branck, T. A., Song, K., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02217-7 · Cited by 177 · see citing works

Psychotropics and the Microbiome: a Chamber of Secrets…

Cussotto, S., Clarke, G. A., Dinan, T. G., & Cryan, J. F. (2019) · Psychopharmacology · doi:10.1007/s00213-019-5185-8 · Cited by 169 · see citing works

Drug–gut microbiota interactions: implications for neuropharmacology

Walsh, J., Griffin, B. T., Clarke, G. A., & Hyland, N. P. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14366 · Cited by 150 · see citing works

On the Colonic Bacterial Metabolism of Azo-Bonded Prodrugsof 5-Aminosalicylic Acid

Sousa, T., Yadav, V., Zann, V., Borde, A., Abrahamsson, B., & Basit, A. W. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24103 · Cited by 144 · see citing works

The anti-inflammatory drug mesalamine targets bacterial polyphosphate accumulation

Dahl, J., Gray, M. J., Bazopoulou, D., Beaufay, F., Lempart, J., Koenigsknecht, M. J., Wang, Y., Baker, J. R., Hasler, W. L., Young, V. B., et al. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.267 · Cited by 130 · see citing works

Identification and Functional Characterization of Arylamine <i>N</i> -Acetyltransferases in Eubacteria: Evidence for Highly Selective Acetylation of 5-Aminosalicylic Acid

Deloménie, C., Fouix, S., Longuemaux, S., Brahimi, N., Bizet, C., Picard, B., Denamur, E., & Dupret, J.-M. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.11.3417-3427.2001 · Cited by 117 · see citing works

Mechanisms of gastrointestinal microflora on drug metabolism in clinical practice

Sun, C., Chen, L., & Shen, Z. (2019) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2019.09.011 · Cited by 90 · see citing works

Human gut microbiota plays a role in the metabolism of drugs

Jourová, L., Anzenbacher, P., & Anzenbacherová, E. (2016) · Biomedical Papers · doi:10.5507/bp.2016.039 · Cited by 75 · see citing works

Expression, purification, characterization and structure of Pseudomonas aeruginosa arylamine N-acetyltransferase

Westwood, I. M., Holton, S. J., Rodrigues‐Lima, F., Dupret, J., Bhakta, S., Noble, M. E. M., & Sim, E. (2005) · Biochemical Journal · doi:10.1042/bj20041330 · Cited by 74 · see citing works

The metabolic effect of gut microbiota on drugs

Xie, Y., Hu, F., Xiang, D., Lu, H., Li, W., Zhao, A., Huang, L., & Wang, R. (2020) · Drug Metabolism Reviews · doi:10.1080/03602532.2020.1718691 · Cited by 72 · see citing works

The role of gut microbiota in the pharmacokinetics of antihypertensive drugs

Choi, M. S., Yu, J. S., Yoo, H. H., & Kim, D. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.01.019 · Cited by 58 · see citing works

Once versus divided daily dosing with delayed‐release mesalazine: a study of tissue drug concentrations and standard pharmacokinetic parameters

Hussain, F., Ajjan, R., Kapur, K. C., Moustafa, M., & Riley, S. A. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.00891.x · Cited by 47 · see citing works

Dose loading with delayed‐release mesalazine: a study of tissue drug concentrations and standard pharmacokinetic parameters

Hussain, F., Ajjan, R., & Riley, S. A. (2000) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2000.00164.x · Cited by 45 · see citing works

Current evidence and clinical relevance of drug-microbiota interactions in inflammatory bowel disease

Becker, H. E. F., Demers, K., Derijks, L. J. J., Jonkers, D. M. A. E., & Penders, J. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1107976 · Cited by 45 · see citing works

Microbiota and Drug Response in Inflammatory Bowel Disease

Franzin, M., Stefančič, K., Lucafò, M., Decorti, G., & Stocco, G. (2021) · Pathogens · doi:10.3390/pathogens10020211 · Cited by 39 · see citing works

The pharmacokinetics of olsalazine sodium in healthy volunteers after a single i.v. dose and after oral doses with and without food

Ryde, E. M., & Ahnfelt, N.-O. (1988) · European Journal of Clinical Pharmacology · doi:10.1007/bf01046706 · Cited by 37 · see citing works

INTESTINAL FATE OF 5‐AMINOSALICYLIC ACID: REGIONAL AND SYSTEMIC KINETIC STUDIES IN RELATION TO INFLAMMATORY BOWEL DISEASE

Bondesen, S. (1997) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1997.tb01944.x · Cited by 28 · see citing works

Dissecting the human gut microbiome to better decipher drug liability: A once-forgotten organ takes center stage

Cai, J., Auster, A., Cho, S., & Lai, Z. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2023.07.002 · Cited by 29 · see citing works

Trametinib, a first-in-class oral MEK inhibitor mass balance study with limited enrollment of two male subjects with advanced cancers

Ho, M. Y. K., Morris, M. J., Pirhalla, J. L., Bauman, J. W., Pendry, C., Orford, K. W., Morrison, R. A., & Cox, D. S. (2013) · Xenobiotica · doi:10.3109/00498254.2013.831143 · Cited by 26 · see citing works

Assessment of the in-vivo drug release from pellets film-coated with a dispersion of high amylose starch and ethylcellulose for potential colon delivery

Freire, C., Podczeck, F., Ferreira, D., Veiga, F., Sousa, J., & Pena, A. (2010) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.62.01.0005 · Cited by 19 · see citing works

Interplay between inflammatory bowel disease therapeutics and the gut microbiome reveals opportunities for novel treatment approaches

O’Reilly, C., Mills, S., Rea, M. C., Lavelle, A., Ghosh, S. K., Hill, C., & Ross, R. P. (2023) · Microbiome Research Reports · doi:10.20517/mrr.2023.41 · Cited by 17 · see citing works

Mesalazine pharmacokinetics and NAT2 phenotype

Lück, H., Kinzig, M., Jetter, A., Fuhr, U., & Sörgel, F. (2008) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-008-0550-2 · Cited by 14 · see citing works

Salicylates and the Microbiota: A New Mechanistic Understanding of an Ancient Drug's Role in Dermatological and Gastrointestinal Disease

Damman, C. J. (2013) · Drug Development Research · doi:10.1002/ddr.21086 · Cited by 10 · see citing works

The Modulation of Drug Efficacy and Toxicity by the Gut Microbiome

Wilson, I. D., & Nicholson, J. K. (2014) · Molecular and integrative toxicology · doi:10.1007/978-1-4471-6539-2_15 · Cited by 9 · see citing works

Modern Sensing Approaches for Predicting Toxicological Responses of Food- and Drug-Based Bioactives on Microbiomes of Gut Origin

Naik, A., & Misra, S. K. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c02736 · Cited by 8 · see citing works

Transformation of Bisphenols by Gut Microbiota: Insights into Species-Specific Pathways and Toxicity Implications

Lv, M., Chen, S., Qin, H., Wang, Y., Liu, Y., Liu, R., Chen, L., Qu, G., & Jiang, G. (2025) · Environmental Science & Technology · doi:10.1021/acs.est.5c01820 · Cited by 7 · see citing works

Cystic fibrosis and inflammatory bowel disease: parallels in gut physiology and microbiota

Barrack, K. E., & O’Toole, G. A. (2025) · Journal of Bacteriology · doi:10.1128/jb.00167-25 · Cited by 6 · see citing works

Emerging Role of Gut Microbiota in Modulating Response to Therapies in IBD

Bartocci, B., Gaudio, A. D., Murgiano, M., Papa, A., Cammarota, G., Gasbarrini, A., Scaldaferri, F., & Lopetuso, L. (2026) · Microorganisms · doi:10.3390/microorganisms14051082 · Cited by 3 · see citing works

Underlying Mechanism of Drug and Non-drug Interactions

Ogbu, J. I., Moreira, C. V. L., Saavedra, R., & Fajemiroye, J. O. (2025) · Springer eBooks · doi:10.1007/978-3-031-80107-5_8 · Cited by 2 · see citing works

Biotransformation by the Gut Microbiome

Chi, L., & Lü, K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64268-x

Faculty Opinions recommendation of Gut microbiome interactions with drug metabolism, efficacy, and toxicity.

Cotter, P. D., & Barton, W. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.726708065.793567416

Intestine Offers Board and Lodging for Intestinal Microbes on a Short- or Long-Term Stay

Blachier, F. (2023) · Springer eBooks · doi:10.1007/978-3-031-26322-4_2

Intestinal Microbiome and Its Impact on Metabolism and Safety of Drugs

Chu, X. Y., & Ho, P. C. (2023) · Wiley eBooks · doi:10.1002/9781119660699.ch25

Decoding the Influence of Gut Microbial Enzymes on Drug Metabolism: Insights and Strategies

Palanisamy, H., & Vidyalakshmi, S. (2025) · Biology Bulletin Reviews · doi:10.1134/s2079086425600419

Gut microbiota impact on drug metabolism, bioavailability, and biotransformation

Boyle, N. R., & Patterson, A. D. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29289-7.00019-9

Xenobiotics: Sources, Fate, and Transport in the Human Body

Reddy, U., Joy, L., Padmanabhan, U., & Jain, A. (2026) · Springer eBooks · doi:10.1007/978-3-032-28619-2_2

The role of enteric bacteria in the anerobic metabolism of 5‐aminosalicylate

Tucker, M. A., Bisesi, M. S., & Smith, T. J. (1989) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.2570040411 · Cited by 2 · see citing works

Colonic N-acetylation of 5-aminosalicylic acid in inflammatory bowel disease

Allgayer, H., Ahnfelt, N.-O., Kruis, W., Klotz, U. E., Frank-Holmberg, K., Söderberg, H. N. A., & Paumgartner, G. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)91412-1 · Cited by 85 · see citing works

Studies on the Acetylating Capacity of Human Colonic Epithelial Cells for 5-Aminosalicylic Acid

Ireland, A., Priddle, J. D., & Jewell, D. P. (1988) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528809101549 · Cited by 4 · see citing works

The Effect of 5-Aminosalicylic Acid on Intestinal Microbiota

Sargautiene, V., Ligere, R., Kalniņa, I., Jākobsone, I., Nikolajeva, V., & Derovs, A. (2020) · Proceedings of the Latvian Academy of Sciences Section B Natural Exact and Applied Sciences · doi:10.2478/prolas-2020-0008 · Cited by 3 · see citing works

Gut microbial metabolism of 5-aminosalicylic acid in inflammatory bowel disease

Karmi, N., Sun, S., Festen, E. A. M., Vila, A. V., Gaćeša, R., & Weersma, R. K. (2024) · Gut · doi:10.1136/gutjnl-2024-332205 · Cited by 9 · see citing works